mardi, 26 juin 2018 08:58

Therachon announces the start of a Natural History Study in Children with Achondroplasia

Written by 
Rate this item
(0 votes)

Therachon AG, a clinical-stage biotechnology company focused on rare diseases, announced the start of "Dreambird", a natural history study of children with achondroplasia, the most common form of dysproportionate short stature in humans.

Read 362 times Last modified on mardi, 26 juin 2018 09:26